Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms

Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms

US Patent 12433941 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating ocular inflammation and chemical injuries of the eye with ex2023
Methods of treating systemic graft-versus-host disease with extracellular vesicl2022
Method of preventing or treating radiation-induced dermatitis with extracellular2020
Extracellular vesicles for agent delivery2019
Tyrosine kinase inhibitors containing a zinc binding moiety2015
Quinazoline based EGFR inhibitors containing a zinc binding moiety2015
Quinazoline based EGFR inhibitors containing a zinc binding moiety2015
Quinazoline based EGFR inhibitors containing a zinc binding moiety2013
Quinazoline based EGFR inhibitors containing a zinc binding moiety2013
Tyrosine kinase inhibitors containing a zinc binding moiety2013
Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety2012
Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety2011